Domestic IVUS Products Approved in 2022, Breaking the Long-standing Monopoly of Overseas Giants
2 day ago / Read about 0 minute
Author:小编   

Intravascular ultrasound (IVUS) is a field where domestic substitution is extremely challenging. For nearly three decades, it has been dominated by Boston Scientific and Philips, characterized by high technical barriers and strong clinical stickiness, making it difficult for domestic manufacturers to enter. It was not until 2022 that the first batch of domestic IVUS products were approved for marketing.